BioCentury | Feb 1, 2020
Company News

Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

...immunotherapy company NeoImmuneTech Inc. promoted Gene Namgoong to COO from general counsel. Drug delivery company Aprecia Pharmaceuticals Co....
BioCentury | Nov 2, 2017
Company News

Management tracks: Melinta, Lundbeck

...was SVP of cancer Biology and co-CSO at OncoMed Pharmaceuticals Inc. (NASDAQ:OMED). Drug delivery company Aprecia Pharmaceuticals Co....
BioCentury | Jul 11, 2016
Financial News

Aprecia completes venture financing

...delivery, Neurology Date completed: 2016-07-05 Type: Venture financing Raised: $20 million Investor: Hercules Capital Note: Aprecia...
BioCentury | Feb 1, 2016
Financial News

Aprecia completes venture financing

Aprecia Pharmaceuticals Co. , Langhorne, Pa. Business: Drug delivery, Neurology Date completed: 2016-01-27 Type: Venture financing Raised: $35 million Investors: Deerfield Management; JW Asset Management LLC Note: The financing includes the conversion of debt to preferred...
BioCentury | Aug 10, 2015
Clinical News

Levetiracetam regulatory update

...FDA approved an NDA from Aprecia for Spritam levetiracetam as an adjunct treatment of seizures in...
...available in 1Q16. The oral levetiracetam is produced using ZipDose Technology, which utilizes 3D printing. Aprecia Pharmaceuticals Co....
BioCentury | Nov 18, 2013
Company News

Aprecia management update

Aprecia Pharmaceuticals Co. , Langhorne, Pa. Business: Drug delivery Hired: Don Wetherhold as CEO, formerly SVP of long-term care at Omnicare Inc. WIR Staff...
Items per page:
1 - 6 of 6
BioCentury | Feb 1, 2020
Company News

Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

...immunotherapy company NeoImmuneTech Inc. promoted Gene Namgoong to COO from general counsel. Drug delivery company Aprecia Pharmaceuticals Co....
BioCentury | Nov 2, 2017
Company News

Management tracks: Melinta, Lundbeck

...was SVP of cancer Biology and co-CSO at OncoMed Pharmaceuticals Inc. (NASDAQ:OMED). Drug delivery company Aprecia Pharmaceuticals Co....
BioCentury | Jul 11, 2016
Financial News

Aprecia completes venture financing

...delivery, Neurology Date completed: 2016-07-05 Type: Venture financing Raised: $20 million Investor: Hercules Capital Note: Aprecia...
BioCentury | Feb 1, 2016
Financial News

Aprecia completes venture financing

Aprecia Pharmaceuticals Co. , Langhorne, Pa. Business: Drug delivery, Neurology Date completed: 2016-01-27 Type: Venture financing Raised: $35 million Investors: Deerfield Management; JW Asset Management LLC Note: The financing includes the conversion of debt to preferred...
BioCentury | Aug 10, 2015
Clinical News

Levetiracetam regulatory update

...FDA approved an NDA from Aprecia for Spritam levetiracetam as an adjunct treatment of seizures in...
...available in 1Q16. The oral levetiracetam is produced using ZipDose Technology, which utilizes 3D printing. Aprecia Pharmaceuticals Co....
BioCentury | Nov 18, 2013
Company News

Aprecia management update

Aprecia Pharmaceuticals Co. , Langhorne, Pa. Business: Drug delivery Hired: Don Wetherhold as CEO, formerly SVP of long-term care at Omnicare Inc. WIR Staff...
Items per page:
1 - 6 of 6